Hims & Hers is shutting down the dermatology business it acquired in 2021, BI has learned. It said it's closing the skincare site Apostrophe to centralize its teledermatology offerings. Hims ...
BofA raised the firm’s price target on Hims & Hers to $21 from $18 and keeps an Underperform rating on the shares. The firm increased Q4 and 2025 revenue and EBITDA estimates, saying feedback ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback